Followers | 806 |
Posts | 30075 |
Boards Moderated | 7 |
Alias Born | 03/22/2016 |
Friday, May 06, 2022 11:25:43 AM
Recent IKNA News
- Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
- Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:01:16 PM
- Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:29:08 PM
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer • GlobeNewswire Inc. • 02/21/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:15:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:07:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:26:52 PM
- Ikena Oncology Outlines Key Priorities and Provides Corporate Updates • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:09:22 PM
- Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
- Ikena Oncology to Present at Multiple November 2023 Investor Conferences • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 09:10:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 08:05:20 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/15/2023 08:05:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/12/2023 08:11:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/11/2023 04:15:23 AM
- Ikena Oncology to Participate in September 2023 Investor Conferences • GlobeNewswire Inc. • 09/05/2023 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/18/2023 08:02:27 PM
- Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update • GlobeNewswire Inc. • 08/10/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 11:00:57 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM